Key Viral Hepatitis Studies Influencing My Practice Following EASL 2019

Join Nancy Reau, MD, or Stefan Zeuzem, MD, as they review the latest practice-changing data on HCV and HBV from the 2019 EASL meeting in Vienna! Hear their take on what you should be doing in your clinic and get answers to your questions in this interactive, CME/CE-certified Webinar.


Key Viral Hepatitis Studies Influencing My Practice Following EASL 2019

  • Program Overview (5 mins)
  • Updating My Practice Following EASL 2019 (25 mins)
    • Summary of the most important viral hepatitis studies
    • Key practice recommendations for the clinic
  • Question and Answer Session (15 mins)


Date / Time
Event Details


Nancy Reau, MD

Professor of Medicine
Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Stefan Zeuzem, MD

Professor of Medicine 
Chief, Department of Medicine I 
JW Goethe University Hospital 
Frankfurt, Germany

Goal Statement
The goal of this activity is to improve participants’ competence in translating the most clinically important data from EASL 2019 into practical management strategies for patients with viral hepatitis.

Target Audience 
This program is intended for physicians, pharmacists, and other healthcare providers who care for patients with viral hepatitis.

Learning Objectives

  • Integrate the results of recent clinical studies of viral hepatitis into clinical practice
  • Evaluate the impact of results of clinical studies of current and investigational treatments for chronic hepatitis C and B on patient management strategies


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education
CCO designates this continuing education activity for 0.75 contact hour (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-19-018-L01-P.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.